TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash Read More
Angle Reports Parsortix System Can Isolate Circulating Tumour Cells Read More
LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal Read More
DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares Read More
UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale Read More
UPDATE: Angle Successfully Raises GBP20 Million In Placing Read More
IN BRIEF: Angle To Raise GBP20 Million To Fund Operations Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer Read More
IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
Angle's Parsortix Able To Predict Patients' Response To Treatment Read More
IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix Read More
Angle Progresses On Parsortix And De Novo Clearance From US Regulator Read More
IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board Read More
Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects Read More
UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE Read More
UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial Read More
Angle Parsortix Test Used To Help Discover Brain Metastasis Read More
